Compare ARK Genomic Revolution ETF (ARKG) vs Berkshire Hathaway Inc Class B (BRK.B) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Berkshire Hathaway Inc Class B — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Berkshire Hathaway Inc Class B trades at $495.25. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Berkshire Hathaway Inc Class B nearer its low. Which is the better fit depends on your goals.
| ARKG | BRK.B | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $513.70 |
52-Week Low | $23.09 | $459.10 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Berkshire Hathaway Class B shares (BRK.B) traded at $493.54, down 0.41% with a bearish technical signal. The stock shows mixed technical indicators with bullish moving averages but neutral oscillators. Analyst sentiment remains positive with 57% buy ratings and no sell recommendations. Support levels are established at $488-$492, while resistance sits at $497-$501.
The investment outlook remains favorable given strong analyst support and Berkshire's diversified business model. Key risks include market volatility and economic sensitivity, but the company's long-term track record provides stability. Earnings growth and portfolio performance will drive future price appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Berkshire Hathaway Inc Class B
Berkshire Hathaway is a holding company with diverse subsidiaries, primarily in insurance through Geico and its reinsurance groups. It reinvests profits into various industries, owning Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy, and major manufacturing, service, and retail businesses like Precision Castparts and Lubrizol. The company operates in a highly decentralized manner.
Read more on BRK.B →
